RECENT NEWS
Pfizer just had a big setback in its race for an Ozempic competitor
Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options
Here's how much Ozempic and similar drugs have soared in popularity since 2018
Eli Lilly is coming after makers of copycat versions of Zepbound